My NCBI | Sign In
Search: plague[mh] AND vaccines[mh] AND English[la] AND human[mh]
RSS Settings
  • Search: plague[mh] AND vaccines[mh] AND English[la] AND human[mh]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 99

    1.

    Plague into the 21st century.

    Butler T.

    Clin Infect Dis. 2009 Sep 1;49(5):736-42. Review. No abstract available. PMID: 19606935 [PubMed - indexed for MEDLINE]Related articles

    2.

    Different pathologies but equal levels of responsiveness to the recombinant F1 and V antigen vaccine and ciprofloxacin in a murine model of plague caused by small- and large-particle aerosols.

    Thomas RJ, Webber D, Collinge A, Stagg AJ, Bailey SC, Nunez A, Gates A, Jayasekera PN, Taylor RR, Eley S, Titball RW.

    Infect Immun. 2009 Apr;77(4):1315-23. Epub 2009 Feb 2.PMID: 19188359 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Pneumonic plague pathogenesis and immunity in Brown Norway rats.

    Anderson DM, Ciletti NA, Lee-Lewis H, Elli D, Segal J, DeBord KL, Overheim KA, Tretiakova M, Brubaker RR, Schneewind O.

    Am J Pathol. 2009 Mar;174(3):910-21. Epub 2009 Jan 22.PMID: 19164505 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Immune defense against pneumonic plague.

    Smiley ST.

    Immunol Rev. 2008 Oct;225:256-71. Review.PMID: 18837787 [PubMed - indexed for MEDLINE]Related articles

    5.

    Lipid A mimetics are potent adjuvants for an intranasal pneumonic plague vaccine.

    Airhart CL, Rohde HN, Hovde CJ, Bohach GA, Deobald CF, Lee SS, Minnich SA.

    Vaccine. 2008 Oct 16;26(44):5554-61. Epub 2008 Aug 21.PMID: 18722493 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Oral vaccination against bubonic plague using a live avirulent Yersinia pseudotuberculosis strain.

    Blisnick T, Ave P, Huerre M, Carniel E, Demeure CE.

    Infect Immun. 2008 Aug;76(8):3808-16. Epub 2008 May 27.PMID: 18505804 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Current challenges in the development of vaccines for pneumonic plague.

    Smiley ST.

    Expert Rev Vaccines. 2008 Mar;7(2):209-21. Review.PMID: 18324890 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Protective immunity against plague.

    Cornelius C, Quenee L, Anderson D, Schneewind O.

    Adv Exp Med Biol. 2007;603:415-24. Review.PMID: 17966437 [PubMed - indexed for MEDLINE]Related articles

    9.

    Yersinia pestis YadC: a novel vaccine candidate against plague.

    Murphy BS, Wulff CR, Garvy BA, Straley SC.

    Adv Exp Med Biol. 2007;603:400-14.PMID: 17966436 [PubMed - indexed for MEDLINE]Related articles

    10.

    Cell-mediated defense against Yersinia pestis infection.

    Smiley ST.

    Adv Exp Med Biol. 2007;603:376-86. Review.PMID: 17966434 [PubMed - indexed for MEDLINE]Related articles

    11.

    Inevitable or avoidable? Despite the lessons of history, the world is not yet ready to face the next great plague.

    Hunter P.

    EMBO Rep. 2007 Jun;8(6):531-4. No abstract available. PMID: 17545992 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Plague.

    Prentice MB, Rahalison L.

    Lancet. 2007 Apr 7;369(9568):1196-207. Review.PMID: 17416264 [PubMed - indexed for MEDLINE]Related articles

    13.

    Development of in vitro correlate assays of immunity to infection with Yersinia pestis.

    Bashaw J, Norris S, Weeks S, Trevino S, Adamovicz JJ, Welkos S.

    Clin Vaccine Immunol. 2007 May;14(5):605-16. Epub 2007 Mar 21.PMID: 17376861 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Waldemar Mordecai Haffkine, CIE (1860-1930): prophylactic vaccination against cholera and bubonic plague in British India.

    Hawgood BJ.

    J Med Biogr. 2007 Feb;15(1):9-19.PMID: 17356724 [PubMed - indexed for MEDLINE]Related articles

    15.

    Development of a recombinant vaccine against aerosolized plague.

    Morris SR.

    Vaccine. 2007 Apr 20;25(16):3115-7. Epub 2007 Jan 30.PMID: 17291640 [PubMed - indexed for MEDLINE]Related articles

    16.

    Human cytolytic T cell recognition of Yersinia pestis virulence proteins that target innate immune responses.

    Saikh KU, Kissner TL, Dyas B, Tropea JE, Waugh DS, Ulrich RG.

    J Infect Dis. 2006 Dec 15;194(12):1753-60. Epub 2006 Nov 2.PMID: 17109349 [PubMed - indexed for MEDLINE]Related articles

    17.

    Virulence factors of Yersinia pestis are overcome by a strong lipopolysaccharide response.

    Montminy SW, Khan N, McGrath S, Walkowicz MJ, Sharp F, Conlon JE, Fukase K, Kusumoto S, Sweet C, Miyake K, Akira S, Cotter RJ, Goguen JD, Lien E.

    Nat Immunol. 2006 Oct;7(10):1066-73. Epub 2006 Sep 17.PMID: 16980981 [PubMed - indexed for MEDLINE]Related articles

    18.

    Sequential proteolytic processing of the capsular Caf1 antigen of Yersinia pestis for major histocompatibility complex class II-restricted presentation to T lymphocytes.

    Musson JA, Morton M, Walker N, Harper HM, McNeill HV, Williamson ED, Robinson JH.

    J Biol Chem. 2006 Sep 8;281(36):26129-35. Epub 2006 Jul 13.PMID: 16840777 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Long-lasting T cell responses to biological warfare vaccines in human vaccinees.

    Allen JS, Skowera A, Rubin GJ, Wessely S, Peakman M.

    Clin Infect Dis. 2006 Jul 1;43(1):1-7. Epub 2006 May 23.PMID: 16758411 [PubMed - indexed for MEDLINE]Related articles

    20.

    Influenza.

    Gershen BJ.

    Md Med. 2006 Winter;7(1):32-3. No abstract available. PMID: 16613366 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    15 free full-text articles in PubMed Central

    Find related data

    Search details

    » See more...

    Recent activity